TY - JOUR
T1 - Effect of insoluble excipients on performance of direct compression controlled release matrices
AU - Laguna-López, Sara
AU - Angulo-Delgado, Cesar R.
AU - Villafuerte-Robles, Leopoldo
N1 - Publisher Copyright:
© 2015, Colegio de Farmaceuticos de la Provincia de Buenos Aires. All rights reserved.
PY - 2015
Y1 - 2015
N2 - This work aimed the assessment of the effect of the insoluble diluents microcrystalline cellulose (MCC) and dicalcium phosphate dihydrate (DCP) on performance of hydrophilic controlled release matrices of hydroxypropyl methylcellulose (HPMC) and Noveon AA1. The performance of powder blends and matrix tablets was determined using dissolution and compactibility profiles and the powders compressibility index. Increasing proportions of DCP produce initially a decrease and thereafter an increase in the dissolution rate of metronidazole. Noveon AA1 matrices displays n values near to zero order release (n = 0.95), decreasing gradually up to 0.68 with increasing proportions of DCP. Metronidazole/MCC matrices containing Noveon AA1 display an almost 100% greater compactibility than those containing HPMC. MCC potentiates the agglutinant functionality of both matrix-forming polymers. Addition of a brittle material such as DCP displays a modest effect on metronidazole matrices compactibility. MCC reduces the effect of Noveon AA1 to decrease the flowability of metronidazole/HPMC powder blends. The effect of DCP is a dramatically increase in flowability of blends of metronidazole containing high proportions of Noveon AA1 (25%).
AB - This work aimed the assessment of the effect of the insoluble diluents microcrystalline cellulose (MCC) and dicalcium phosphate dihydrate (DCP) on performance of hydrophilic controlled release matrices of hydroxypropyl methylcellulose (HPMC) and Noveon AA1. The performance of powder blends and matrix tablets was determined using dissolution and compactibility profiles and the powders compressibility index. Increasing proportions of DCP produce initially a decrease and thereafter an increase in the dissolution rate of metronidazole. Noveon AA1 matrices displays n values near to zero order release (n = 0.95), decreasing gradually up to 0.68 with increasing proportions of DCP. Metronidazole/MCC matrices containing Noveon AA1 display an almost 100% greater compactibility than those containing HPMC. MCC potentiates the agglutinant functionality of both matrix-forming polymers. Addition of a brittle material such as DCP displays a modest effect on metronidazole matrices compactibility. MCC reduces the effect of Noveon AA1 to decrease the flowability of metronidazole/HPMC powder blends. The effect of DCP is a dramatically increase in flowability of blends of metronidazole containing high proportions of Noveon AA1 (25%).
KW - Compactibility profiles
KW - Compressibility index
KW - Dissolution profiles
KW - Metronidazole
KW - Powder flowability
KW - Release mechanisms
UR - http://www.scopus.com/inward/record.url?scp=84926433972&partnerID=8YFLogxK
M3 - Artículo
SN - 0326-2383
VL - 34
SP - 552
EP - 561
JO - Latin American Journal of Pharmacy
JF - Latin American Journal of Pharmacy
IS - 3
ER -